Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Deferred Tax Assets / Liabilities ₹8.67 Cr₹48 Cr₹16 Cr₹-36 Cr₹-40 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of MANKIND PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of MANKIND PHARMA is ₹8.67 Cr based on Mar2024 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2024₹8.67 Cr
Mar2023₹48 Cr
Mar2022₹16 Cr
Mar2021₹-36 Cr
Mar2020₹-40 Cr

How is Deferred Tax Assets / Liabilities of MANKIND PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2024 ₹8.67 Cr
-81.76
Mar2023 ₹48 Cr
191.02
Mar2022 ₹16 Cr
Positive
Mar2021 ₹-36 Cr
Negative
Mar2020 ₹-40 Cr -

Compare Deferred Tax Assets / Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹101,468.7 Cr -4.1% -14.4% 17% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,461.0 Cr 1.4% -4.1% 32.1% Stock Analytics
DIVIS LABORATORIES ₹147,983.0 Cr -4.2% -5.1% 59.6% Stock Analytics
CIPLA ₹112,735.0 Cr -2.2% -7.3% 0.2% Stock Analytics
DR REDDYS LABORATORIES ₹99,913.9 Cr -7.1% -13.8% 8% Stock Analytics
ZYDUS LIFESCIENCES ₹92,815.0 Cr -6.4% -5.2% 31.2% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-4.1%

-14.4%

17%

SENSEX

-2.2%

-4%

5.5%


You may also like the below Video Courses